Medicare Advantage plans must cover Biogen’s (NASDAQ:BIIB) drug Qalsody for the treatment of ALS, according to a report. The U.S. Centers for Medicare & Medicaid Services has directed insurance ...

Hopes of a bright new future in stroke risk management in AF were dashed when asundexian failed against apixaban in the ...

Keros Therapeutics (NASDAQ:KROS) stock plunged 73% Thursday after the company said it has halted two arms of a Phase 2 clinical study of its drug cibotercept in patients with pulmonary arterial ...

The experimental therapy Bravyl significantly reduced the spread of toxic TDP-43 protein clumps in a cell model of ALS.

Two gout experts debated whether first-line urate-lowering therapy should consist of a xanthine oxidase inhibitor or should ...

Bristol-Myers Squibb has won FDA approval for the first LAG-3 inhibitor ... is a clutch of drugs in mid-stage development, including Immutep's soluble LAG-3 protein eftilagimod alpha, Novartis ...

The hope is that the two drugs could be combined with new KRAS inhibitor drugs from Amgen and Mirati to improve their efficacy, as well as potentially a dual therapy for other cancers. BridgeBio ...

San Antonio Breast Cancer Conference featured updates on VEGF bispecifics, oral protein degraders, and data from BeiGene, ...

11 x 23 in. (27.9 x 58.4 cm.) ...

Alpha is a smartphone brand supported by Indian e-commerce website Snapdeal, as part of the retailer's Launchpad programme. Alpha unveiled its first Android smartphone, called Feather, in July 2014.

*Those medicines on the acute hospital formulary are restricted to hospital use only. NELFT staff should not prescribe these medicines unless there are special agreements in place i.e. shared care ...

The net prices of five drugs included in a new study from the Institute for Clinical and Economic Review increased without clinical justification in 2023. These increases led to $815 million ...